John James Rickard Macleod (1876–1935) was a renowned British biochemist and physiologist whose greatest contribution to medical science was the discovery and isolation of insulin. He shared the 1923 Nobel Prize in Physiology or Medicine with Frederick Banting for this revolutionary work, which transformed diabetes from a fatal disease into a manageable condition.
Macleod’s expertise in carbohydrate metabolism and his guidance at the University of Toronto played a pivotal role in advancing insulin research, enabling the first successful treatments of diabetes. Though his role was initially downplayed, later historical reviews have confirmed his critical involvement in experimental design, analysis, and dissemination of results.
Throughout his career, he authored several landmark works including “Insulin and its Use in Diabetes” and “Carbohydrate Metabolism and Insulin.” He was honored globally and elected to prestigious societies such as the Royal Society and Leopoldina.
To celebrate his legacy, the 2nd World Congress on Diabetes and Endocrinology – 2026 is proud to present the John Macleod Memorial Award to recognize outstanding contributions by mid-career researchers in the field of diabetes and endocrinology.
Two top-rated abstracts will be shortlisted prior to the event. The selected winner will be awarded at the 2nd World Congress on Diabetes and Endocrinology – 2026 in Dubai, UAE.
Interested candidates should email their nomination to: [email protected]< with the following documents:
We invite emerging leaders in diabetes and endocrinology research to participate and be recognized for their commitment to innovation, discovery, and translational science in honor of John Macleod’s enduring legacy.
